Detalhe da pesquisa
1.
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.
Proc Natl Acad Sci U S A
; 119(3)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031563
2.
Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study.
Eur J Haematol
; 111(4): 636-643, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492929
3.
Effect of Positioning of the Region of Interest on Bone Density of the Hip.
J Clin Densitom
; 23(3): 426-431, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036446
4.
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.
Clin Cancer Res
; 30(9): 1889-1905, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381406
5.
The Use of Radiomic Features to Predict Human Papillomavirus (HPV) Status in Head and Neck Tumors: A Review.
Cureus
; 15(8): e44476, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664330
6.
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Cancer Res
; 83(19): 3284-3304, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450351
7.
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Cancer Res
; 82(20): 3673-3686, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950920
8.
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.
Nat Commun
; 13(1): 2559, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562350
9.
CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq Analysis.
Genomics Proteomics Bioinformatics
; 19(4): 652-661, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284136
10.
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition.
Sci Adv
; 6(25): eabb2210, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32704543